Health-related Quality of Life Among Older Adults Following Acute Hospitalization: Longitudinal Analysis of a Randomized Controlled Trial

Overview

Journal Qual Life Res

Specialties Pharmacology
Rehabilitation Medicine

Date 2024 Jun 17

PMID 38884880

Authors

Eirin Guldsten Robinson

Hanna Gyllensten

Anne Gerd Granas

Kjell H Halvorsen

Beate Hennie Garcia

Affiliations

Soon will be listed here.

Abstract

Purpose: To describe the longitudinal change of health-related quality of life (HRQoL) over 12 months from acute hospitalization in older adults ≥ 70 years (IMMENSE study), and associated factors, to investigate how a medication optimization intervention influenced this change.

Methods: The EQ-5D-3L was used at discharge and 1, 6 and 12 months after discharge during a randomized controlled trial including 285 participants. Multilevel logistic (EQ-5D-3L dimensions) and mixed model regression (EQ-5D-3L index scores, EQ-VAS) were used to explore the longitudinal change with/without the intervention, and associations with medications, comorbidities, and socioeconomic variables. Subgroup analyses were performed for non-long and long stayers with hospitalizations < or ≥ 14 days.

Results: EQ-5D-3L index scores significantly declined after 12 months (β -0.06 [95% confidence interval (CI:) -0.10--0.02], p = 0.003). Non-long stayers showed significant improvement 1 month from discharge (β 0.05 [0.00-0.09], p = 0.040). The number of medications and receiving home-care services were the main factors associated with reduced HRQoL. Being home-dwelling was the main factor associated with higher HRQoL. Non-long stayers of the intervention group reported significantly higher EQ-VAS than the control group (β 4.02 [0.11-7.93], p = 0.044).

Conclusion: We observed no significant difference in the longitudinal change in HRQoL between the two IMMENSE study groups over 12 months after hospitalization. However, the non-long stayer subgroup analysis indicates that the intervention may have had a long-term effect on HRQoL in some of intervention patients. The number of medications and the ability to live and care for oneself should be taken into consideration when planning future patient care and health-care services.

Trial Registration: The trial was registered in clinicaltrials.gov on 28/06/2016 before enrolment started (NCT02816086).

Citing Articles

Investigating the impact of a pharmacist intervention on inappropriate prescribing practices at hospital admission and discharge in older patients: a secondary outcome analysis from a randomized controlled trial.

Garcia B, Omma K, Smabrekke L, Johansen J, Skjold F, Halvorsen K Ther Adv Drug Saf. 2024; 15:20420986241299683.

PMID: 39555108 PMC: 11569490. DOI: 10.1177/20420986241299683.

References

Twisk J, de Boer M, de Vente W, Heymans M . Multiple imputation of missing values was not necessary before performing a longitudinal mixed-model analysis. J Clin Epidemiol. 2013; 66(9):1022-8. DOI: 10.1016/j.jclinepi.2013.03.017. View

Konig H, Heider D, Lehnert T, Riedel-Heller S, Angermeyer M, Matschinger H . Health status of the advanced elderly in six European countries: results from a representative survey using EQ-5D and SF-12. Health Qual Life Outcomes. 2010; 8:143. PMC: 3009699. DOI: 10.1186/1477-7525-8-143. View

Aljeaidi M, Haaksma M, Tan E . Polypharmacy and trajectories of health-related quality of life in older adults: an Australian cohort study. Qual Life Res. 2022; 31(9):2663-2671. PMC: 9356923. DOI: 10.1007/s11136-022-03136-9. View

Wilk P, Ruiz-Castell M, Stranges S, Bohn T, Fagherazzi G, Nicholson K . Relationship between multimorbidity, functional limitation, and quality of life among middle-aged and older adults: findings from the longitudinal analysis of the 2013-2020 Survey of Health, Ageing, and Retirement in Europe (SHARE). Qual Life Res. 2023; 33(1):169-181. PMC: 10784342. DOI: 10.1007/s11136-023-03508-9. View

Gabrio A, Plumpton C, Banerjee S, Leurent B . Linear mixed models to handle missing at random data in trial-based economic evaluations. Health Econ. 2022; 31(6):1276-1287. PMC: 9325521. DOI: 10.1002/hec.4510. View

Janssen M, Szende A, Cabases J, Ramos-Goni J, Vilagut G, Konig H . Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries. Eur J Health Econ. 2018; 20(2):205-216. PMC: 6438939. DOI: 10.1007/s10198-018-0955-5. View

Johansen J, Halvorsen K, Svendsen K, Havnes K, Robinson E, Wetting H . Interdisciplinary collaboration across secondary and primary care to improve medication safety in the elderly (The IMMENSE study) - a randomized controlled trial. BMC Health Serv Res. 2022; 22(1):1290. PMC: 9597977. DOI: 10.1186/s12913-022-08648-1. View

Romskaug R, Skovlund E, Straand J, Molden E, Kersten H, Pitkala K . Effect of Clinical Geriatric Assessments and Collaborative Medication Reviews by Geriatrician and Family Physician for Improving Health-Related Quality of Life in Home-Dwelling Older Patients Receiving Polypharmacy: A Cluster Randomized Clinical.... JAMA Intern Med. 2019; 180(2):181-189. PMC: 6802420. DOI: 10.1001/jamainternmed.2019.5096. View

Sunde S, Hesseberg K, Skelton D, Ranhoff A, Pripp A, Aaronaes M . Associations between health-related quality of life and physical function in older adults with or at risk of mobility disability after discharge from the hospital. Eur Geriatr Med. 2021; 12(6):1247-1256. PMC: 8626396. DOI: 10.1007/s41999-021-00525-0. View

10.

Marten O, Greiner W . EQ-5D-5L reference values for the German general elderly population. Health Qual Life Outcomes. 2021; 19(1):76. PMC: 7937199. DOI: 10.1186/s12955-021-01719-7. View

11.

Lea M, Mowe M, Molden E, Kvernrod K, Skovlund E, Mathiesen L . Effect of medicines management versus standard care on readmissions in multimorbid patients: a randomised controlled trial. BMJ Open. 2020; 10(12):e041558. PMC: 7778779. DOI: 10.1136/bmjopen-2020-041558. View

12.

Luo N, Johnson J, Coons S . Using instrument-defined health state transitions to estimate minimally important differences for four preference-based health-related quality of life instruments. Med Care. 2010; 48(4):365-71. DOI: 10.1097/mlr.0b013e3181c162a2. View

13.

Mangen M, Bolkenbaas M, Huijts S, van Werkhoven C, Bonten M, de Wit G . Quality of life in community-dwelling Dutch elderly measured by EQ-5D-3L. Health Qual Life Outcomes. 2017; 15(1):3. PMC: 5220621. DOI: 10.1186/s12955-016-0577-5. View

14.

Bulow C, Clausen S, Lundh A, Christensen M . Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev. 2023; 1:CD008986. PMC: 9869657. DOI: 10.1002/14651858.CD008986.pub4. View

15.

Walters S, Brazier J . Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005; 14(6):1523-32. DOI: 10.1007/s11136-004-7713-0. View

16.

Johansen J, Halvorsen K, Havnes K, Wetting H, Svendsen K, Garcia B . Intervention fidelity and process outcomes of the IMMENSE study, a pharmacist-led interdisciplinary intervention to improve medication safety in older hospitalized patients. J Clin Pharm Ther. 2021; 47(5):619-627. DOI: 10.1111/jcpt.13581. View

17.

Griffiths A, Paracha N, Davies A, Branscombe N, Cowie M, Sculpher M . Analyzing Health-Related Quality of Life Data to Estimate Parameters for Cost-Effectiveness Models: An Example Using Longitudinal EQ-5D Data from the SHIFT Randomized Controlled Trial. Adv Ther. 2017; 34(3):753-764. PMC: 5350196. DOI: 10.1007/s12325-016-0471-x. View

18.

Waehler I, Saltvedt I, Lydersen S, Fure B, Askim T, Einstad M . Association between in-hospital frailty and health-related quality of life after stroke: the Nor-COAST study. BMC Neurol. 2021; 21(1):100. PMC: 7931593. DOI: 10.1186/s12883-021-02128-5. View

19.

Johansen J, Havnes K, Halvorsen K, Haustreis S, Skaue L, Kamycheva E . Interdisciplinary collaboration across secondary and primary care to improve medication safety in the elderly (IMMENSE study): study protocol for a randomised controlled trial. BMJ Open. 2018; 8(1):e020106. PMC: 5786089. DOI: 10.1136/bmjopen-2017-020106. View

20.

Stavem K, Augestad L, Kristiansen I, Rand K . General population norms for the EQ-5D-3 L in Norway: comparison of postal and web surveys. Health Qual Life Outcomes. 2018; 16(1):204. PMC: 6194590. DOI: 10.1186/s12955-018-1029-1. View